Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4451
Gerdau
GGB
$10B
| $624K | ﹤0.01% |
441,329
-1,702,051
| -79% | -$1.51M |
|
4452
PUT
Marvell Technology
MRVL
$191B
| $624K | ﹤0.01% |
60,500
+33,200
| +122% | +$306K |
|
|
NPKI
4453
NPK International
NPKI
$1.16B
| $622K | ﹤0.01% |
143,988
+44,434
| +45% | +$190K |
|
4454
Albany International
AIN
$1.73B
| $621K | ﹤0.01% |
16,544
+8,039
| +95% | +$283K |
|
4455
CALL
Sinclair Inc
SBGI
$1.14B
| $621K | ﹤0.01% |
20,200
+8,300
| +70% | +$255K |
|
|
FFWM
4456
DELISTED
First Foundation Inc
FFWM
| $620K | ﹤0.01% |
+55,240
| New | +$608K |
|
|
NETI
4457
DELISTED
Eneti Inc.
NETI
| $620K | ﹤0.01% |
20,341
-123,442
| -86% | -$3.87M |
|
|
IDTI
4458
CALL
DELISTED
Integrated Device Technology I
IDTI
| $619K | ﹤0.01% |
30,300
-25,000
| -45% | -$525K |
|
4459
Artivion
AORT
$1.34B
| $618K | ﹤0.01% |
+57,500
| New | +$585K |
|
4460
PUT
Bunge Global
BG
$20.9B
| $618K | ﹤0.01% |
10,900
-84,800
| -89% | -$4.84M |
|
4461
PUT
O-I Glass
OI
$1.1B
| $618K | ﹤0.01% |
38,700
+33,800
| +690% | +$484K |
|
4462
PLDT
PHI
$4.33B
| $617K | ﹤0.01% |
14,235
+8,950
| +169% | +$381K |
|
|
KDNY
4463
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $617K | ﹤0.01% |
9,638
+2,338
| +32% | +$189K |
|
|
AJRD
4464
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $616K | ﹤0.01% |
+37,612
| New | +$588K |
|
|
SPN
4465
CALL
DELISTED
Superior Energy Services, Inc.
SPN
| $616K | ﹤0.01% |
+4,600
| New | +$501K |
|
4466
KRONOS Worldwide
KRO
$985M
| $615K | ﹤0.01% |
107,451
+57,436
| +115% | +$299K |
|
|
BSJI
4467
DELISTED
Invesco BulletShares 2018 High Yield Corporate Bond ETF
BSJI
| $615K | ﹤0.01% |
25,476
+867
| +4% | +$20.4K |
|
4468
CALL
AstraZeneca
AZN
$249B
| $614K | ﹤0.01% |
10,900
-54,150
| -83% | -$3.25M |
|
4469
PUT
Canadian Solar
CSIQ
$1.05B
| $613K | ﹤0.01% |
31,800
-49,100
| -61% | -$1.01M |
|
|
STI
4470
PUT
DELISTED
SunTrust Banks, Inc.
STI
| $613K | ﹤0.01% |
17,000
-253,500
| -94% | -$9.13M |
|
|
CPN
4471
PUT
DELISTED
Calpine Corporation
CPN
| $613K | ﹤0.01% |
40,400
| – | – |
|
|
JASO
4472
DELISTED
JA Solar Holdings, Co., Ltd
JASO
| $612K | ﹤0.01% |
71,024
+36,250
| +104% | +$319K |
|
|
IXYS
4473
DELISTED
IXYS Corp
IXYS
| $612K | ﹤0.01% |
54,518
+42,750
| +363% | +$485K |
|
4474
Crocs
CROX
$6.44B
| $611K | ﹤0.01% |
63,483
-42,860
| -40% | -$399K |
|
4475
CALL
Dover
DOV
$28.4B
| $611K | ﹤0.01% |
11,761
+6,685
| +132% | +$324K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.